Search results
COVID summer wave grows, especially in West, with new variant LB.1 on the rise
CBS News· 17 hours agoA summertime wave of COVID-19 infections is arriving earlier than last year across a growing share...
25,274 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Los Angeles Capital Management LLC
ETF DAILY NEWS· 7 hours agoLos Angeles Capital Management LLC acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) during the 1st quarter, according to its most recent 13F ...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 5 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Gateway - Quartz
Quartz· 3 days agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical trial ...
COVID-19 is surging. Time to mask up or get a booster? What a Boise medical expert says
Idaho Statesman McClatchy via AOL· 1 day agoThe Centers for Disease Control and Prevention recommends everyone 6 months and older get an updated...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 2 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Moderna Just Gave Investors Another Reason to Buy the Stock | The Motley Fool
The Motley Fool· 6 days agoModerna (MRNA -3.58%) is best known for its work in the coronavirus vaccine market. Let's look...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoBut Moderna expects the lion's share of its sales to come in the second half of 2024. That lines up...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 4 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated COVID...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 2 days agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...